From white coat hypertension and resistant hypertension to diet and exercise and multiple drug therapy: you'll find practical guidance here.
New Hypertension Guidelines: 7 Highs and Lows
The ACP and AAFP provide evidence-based recommendations on the benefits and harms of higher vs lower systolic blood pressure targets.
120: The New Normal?
Podcast: Hypertension expert Daichi Shimbo, MD, offers tips on putting SPRINT results into clinical practice.
BP Variability Does More Damage than Hypertension Alone
Dr Bobby Lazzara reviews a new study that suggests reducing fluctuations in blood pressure in older adults could help prevent loss of cognitive function and verbal memory.
Treatment of Hypertension in the Frail Elderly Population
Assessment of frailty status, as well as chronological age, should be used to make clinical decisions.
HOPE-3: Blood Pressure Lowering Alone Fails to Deliver For Some
Although results of the hypertension portion of HOPE-3 were disappointing, many caveats are offered to explain the outcome.
CardioBrief: Slow Down Urged on SPRINT
The 25% reduction in relative risk seen in patients treated to 120 vs 140 mm Hg corresponds to an absolute risk reduction of 1.6%.
Time to Retire Beta-Blockers in Uncomplicated Hypertension?
A comprehensive review of the evidence for the work-horse drugs indicates it's not quite time, yet.
By clicking Accept, you agree to become a member of the UBM Medica Community.